| |
| |
|
| Insider
Information: |
Davis Stephen |
| Relationship: |
Director |
| City: |
Branford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
344,117 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,513,419 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
344,117 |
|
|
| Total
Value |
$2,513,419 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
16
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -96.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Heron Therapeutics Inc |
HRTX |
Director |
2022-12-16 |
52,032 |
2010-02-17 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
EVP & COO |
2012-06-19 |
0 |
2010-04-06 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director |
2014-07-02 |
0 |
2013-05-24 |
0 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2024-05-02 |
155,231 |
2019-10-09 |
0 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
136,854 |
2022-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
95 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2012-06-19 |
4 |
D |
$32.00 |
$515,168 |
D/D |
(16,099) |
0 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,308) |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2019-10-09 |
4 |
AS |
$40.00 |
$1,191,710 |
D/D |
(29,792) |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2019-10-10 |
4 |
AS |
$40.19 |
$4,831,039 |
D/D |
(120,208) |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2019-10-15 |
4 |
S |
$39.65 |
$118,276 |
D/D |
(2,983) |
2,954 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2019-12-05 |
4 |
AS |
$51.32 |
$7,851,300 |
D/D |
(150,000) |
2,954 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2020-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2013-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,728 |
5,728 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2019-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,937 |
5,937 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
9,308 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2020-04-30 |
4 |
S |
$49.21 |
$333,152 |
D/D |
(6,770) |
11,809 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2020-05-13 |
4 |
AS |
$45.12 |
$5,165,587 |
D/D |
(111,458) |
11,809 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2020-05-14 |
4 |
AS |
$45.01 |
$4,039,105 |
D/D |
(88,542) |
11,809 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,452 |
13,452 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2020-10-16 |
4 |
S |
$42.56 |
$125,978 |
D/D |
(2,960) |
14,786 |
0 |
% |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2012-05-06 |
4 |
D |
$31.70 |
$6,055 |
D/D |
(191) |
15,409 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2012-04-06 |
4 |
D |
$21.92 |
$4,187 |
D/D |
(191) |
15,600 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2012-03-06 |
4 |
D |
$20.33 |
$4,330 |
D/D |
(213) |
15,791 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2012-06-06 |
4 |
D |
$31.96 |
$6,104 |
D/D |
(191) |
15,816 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2012-02-06 |
4 |
D |
$20.20 |
$4,404 |
D/D |
(218) |
16,004 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2012-01-06 |
4 |
AS |
$15.91 |
$11,138 |
D/D |
(700) |
16,222 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2012-01-06 |
4 |
D |
$15.55 |
$3,390 |
D/D |
(218) |
16,922 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-12-06 |
4 |
D |
$19.93 |
$3,807 |
D/D |
(191) |
17,140 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-11-06 |
4 |
D |
$18.81 |
$3,593 |
D/D |
(191) |
17,187 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
EVP & COO |
• – – |
2011-11-15 |
4 |
AS |
$18.86 |
$8,146 |
D/D |
(432) |
17,331 |
0 |
- |
|
95 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
